MIR6722

Across TCGA pan-cancer cohorts, MIR6722 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated MIR6722 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher MIR6722 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR6722 expression acts as an unfavorable survival marker, although some lineages such as ESCA and THCA show a favorable association.

LUSC, ESCA, and LUAD are the cancer types where MIR6722 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Tertile	II,III,IV	0.077	0.736	<.001	60	view →
ESCA	DFS	Tertile	All	1.000	0.498	.001	54	view →
LUAD	DFS	Tertile	All	0.403	0.774	<.001	54	view →
SKCM	OS	Tertile	III,IV	0.198	0.697	.011	45	view →
ACC	OS	Tertile	III,IV	0.390	0.821	<.001	45	view →
COAD	OS	Tertile	All	0.500	0.871	<.001	36	view →
THCA	DFS	Median	All	0.937	0.862	.010	24	view →
BRCA	OS	Tertile	All	0.185	0.582	.024	18	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	18	view →
PCPG	OS	Tertile	All	0.872	0.980	.019	18	view →
GBM	DFS	Tertile	All	0.082	0.292	.016	9	view →
MESO	OS	Tertile	All	0.286	0.551	.049	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

MIR6722–LUSC (OS)

Open the LUSC breakdown →